ProfileJobs (160)

Dexcom

Healthdiabetesmedtechmonitoringwearables

Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management. The Company provides Dexcom Seven that can show a new glucose reading every 5 minutes for up to seven days of uninterrupted wear-time to show where glucose levels are, where they have been and where they are going. The system is made up of three technologies: the sensor, transmitter, and receiver. The sensor is a flexible round wire that goes just under the skin to read glucose levels, and attaches to the skin with an adhesive patch. The transmitter snaps into the sensor; it wirelessly sends glucose information to the Receiver every 5 minutes. The receiver displays glucose levels and trends.

Revenue(Q1, 2017)
$142.3 M
Market capitalization(2017-08-15)
$6.2 B
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1999
Size (employees)
1,900 (est)
Website
dexcom.com
Dexcom was founded in 1999 and is headquartered in San Diego, US

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr

Dexcom Data and Metrics

Dexcom Financial Metrics

Dexcom's revenue was reported to be $142.3 m in Q1, 2017
USD

Revenue (Q1, 2017)

142.3 m

Gross profit (Q1, 2017)

94.1 m

Gross profit margin (Q1, 2017), %

66%

Net income (Q1, 2017)

(41.7 m)

EBIT (Q1, 2017)

(40.4 m)

Market capitalization (15-Aug-2017)

6.2 b

Cash (31-Mar-2017)

153.5 m
Dexcom's current market capitalization is $6.2 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

160 m259.2 m402 m573.3 m

Revenue growth, %

62%55%43%

Cost of goods sold

59.9 m82.9 m123.6 m194.9 m

Gross profit

100.1 m176.3 m278.4 m378.4 m

Gross profit Margin, %

63%68%69%66%

R&D expense

156.1 m

General and administrative expense

286.2 m

Operating expense total

129 m197.8 m335.5 m442.3 m

EBIT

(28.9 m)(21.5 m)(57.1 m)(63.9 m)

EBIT margin, %

(18%)(8%)(14%)(11%)

Interest expense

900 k800 k400 k700 k

Interest income

400 k

Pre tax profit

(29.8 m)(22.3 m)(57.5 m)(64.9 m)

Income tax expense

100 k100 k100 k700 k

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

58.8 m69 m72.8 m93.2 m105.2 m116.2 m137.3 m148.6 m142.3 m

Cost of goods sold

18.9 m21.8 m26.3 m27.2 m30.5 m41.1 m51.8 m47.5 m48.2 m

Gross profit

39.9 m47.2 m46.5 m66 m74.7 m75.1 m85.5 m101.1 m94.1 m

Gross profit Margin, %

68%68%64%71%71%65%62%68%66%

R&D expense

14.8 m18.5 m19.8 m24.4 m64.8 m32.2 m36.3 m43.9 m48.1 m

General and administrative expense

30.9 m33.7 m39.4 m45.2 m52.3 m62.1 m69.3 m75.7 m86.4 m

Operating expense total

45.7 m52.2 m59.2 m69.6 m117.1 m94.3 m105.6 m119.6 m134.5 m

EBIT

(5.8 m)(5 m)(12.7 m)(3.6 m)(42.4 m)(19.2 m)(20.1 m)(18.5 m)(40.4 m)

EBIT margin, %

(10%)(7%)(17%)(4%)(40%)(17%)(15%)(12%)(28%)

Interest expense

(200 k)(200 k)(200 k)(100 k)(100 k)(100 k)(100 k)(200 k)(500 k)

Interest income

200 k

Pre tax profit

(40.3 m)

Income tax expense

100 k200 k1.4 m

Net Income

(18.5 m)(23.7 m)(12.9 m)(16.6 m)(59.1 m)(19.2 m)(39.4 m)(58.2 m)(41.7 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

43.2 m71.8 m86.1 m94.5 m

Accounts Receivable

26.1 m42.4 m74.1 m101.7 m

Inventories

9 m16 m35.2 m45.4 m

Current Assets

93.1 m145.9 m231.3 m280 m

PP&E

20.7 m31.2 m54.7 m109.4 m

Goodwill

3.2 m3.2 m3.7 m11.3 m

Total Assets

122.5 m184.6 m292 m402.8 m

Accounts Payable

68.1 m

Total Debt

6.8 m4.6 m2.3 m

Current Liabilities

32.1 m40.6 m66.9 m102.4 m

Total Liabilities

119 m

Additional Paid-in Capital

559.5 m638 m776.8 m905.7 m

Retained Earnings

(475.4 m)(497.8 m)(555.4 m)(621 m)

Total Equity

84.1 m140.2 m221.2 m283.8 m

Debt to Equity Ratio

0.1 x0 x0 x

Debt to Assets Ratio

0.1 x0 x0 x

Financial Leverage

1.5 x1.3 x1.3 x1.4 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

49.5 m63.2 m54.2 m67.7 m85.3 m77.9 m87.5 m97.7 m153.5 m

Accounts Receivable

28.6 m31.4 m40.2 m45.5 m55.8 m85.9 m

Inventories

11.6 m14.3 m18.4 m22.4 m30.6 m46.1 m42.9 m44.7 m46.5 m

Current Assets

105.5 m123.4 m146.2 m170.4 m203.7 m227.4 m241 m258.6 m330.5 m

PP&E

26 m28 m35.7 m40.6 m46.6 m65.9 m77 m88.4 m123.4 m

Goodwill

3.2 m3.2 m3.2 m3.7 m3.7 m3.7 m11.8 m11.8 m11.4 m

Total Assets

139.7 m159.4 m189.3 m218.4 m256.7 m299.4 m332.8 m361.9 m467.2 m

Accounts Payable

20 m20.9 m21.2 m24 m34.3 m45.1 m49.9 m58.6 m65.4 m

Current Liabilities

35.6 m40.6 m37 m44.2 m58.8 m64.1 m73.9 m86.1 m171.7 m

Additional Paid-in Capital

593.6 m614.1 m659.5 m685.3 m750.4 m806 m841.8 m876 m942.3 m

Retained Earnings

(493.9 m)(499.1 m)(510.7 m)(514.4 m)(556.9 m)(574.6 m)(594.8 m)(613.6 m)(663.3 m)

Total Equity

170.7 m193.3 m231.2 m246.4 m261.8 m277.8 m

Financial Leverage

1.3 x1.3 x1.3 x1.4 x1.4 x1.7 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)

Depreciation and Amortization

7 m8.4 m10.8 m15 m

Accounts Receivable

(6.5 m)(16 m)(32 m)(27.2 m)

Inventories

(1.6 m)(7 m)(19 m)(9.8 m)

Cash From Operating Activities

2.4 m23.6 m49 m56.2 m

Purchases of PP&E

(7.9 m)(16.2 m)(33.3 m)(55.7 m)

Cash From Investing Activities

20.9 m(16.8 m)(51.5 m)(55.9 m)

Long-term Borrowings

(200 k)(2.2 m)(2.3 m)(2.3 m)

Cash From Financing Activities

11.8 m21.8 m16.8 m8.1 m

Interest Paid

500 k400 k300 k100 k

Income Taxes Paid

100 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(18.5 m)(23.7 m)(12.9 m)(16.6 m)(59.1 m)(19.2 m)(39.4 m)(58.2 m)(41.7 m)

Depreciation and Amortization

3.8 m6 m2.4 m5 m7.7 m3.4 m7.3 m11.4 m3.7 m

Accounts Receivable

(2.5 m)(5.3 m)2.2 m(3.1 m)(13.4 m)6.8 m800 k(2.2 m)15.8 m

Inventories

(2.6 m)(5.3 m)(2.4 m)(6.4 m)(14.6 m)(10.9 m)(7.2 m)(8.9 m)(1 m)

Cash From Operating Activities

3.8 m15.2 m3.4 m19.8 m37.7 m(200 k)19.9 m42.9 m300 k

Purchases of PP&E

(7.9 m)(11.6 m)(8 m)(14.3 m)(21.7 m)(11.5 m)(22 m)(38.1 m)(22.9 m)

Cash From Investing Activities

(8.3 m)(12.1 m)(25.9 m)(33.1 m)(38.8 m)(11.2 m)(20.8 m)(38.6 m)(21.4 m)

Long-term Borrowings

(1.1 m)(1.6 m)(600 k)(1.2 m)(1.7 m)(600 k)(2.3 m)(2.3 m)

Cash From Financing Activities

10.8 m16.9 m4.9 m9.2 m14.6 m3.2 m2.5 m7.6 m80.3 m
USDY, 2017

Revenue/Employee

74.9 k

Financial Leverage

1.7 x

Dexcom Operating Metrics

FY, 2016

Patents (US)

334

Patents (foreign)

48

Patents Pending

417

Trademarks (US)

24

Trademarks (foreign)

54

Trademarks Pending

38

Facilities

2

Dexcom Market Value History

Dexcom Revenue Breakdown

Dexcom Job Categories

Dexcom Median Salaries

Source: 23 public H-1B filings from Dexcom

Market Position of Dexcom

Competitors

HCi Viocare
Health - Public
Echo Therapeutics
Health - Public
Hinge Health
Health - Private
Lidco Group
Health - Public
Compare competitors

Traffic Overview of Dexcom

Dexcom Online and Social Media Presence

Dexcom News and Updates

October 17, 2016

Dexcom's Blood Sugar Monitor Has Been A Life-Changer For This Diabetic

The device includes a small sensor, placed just beneath the skin of my belly, and displays my blood glucose levels right on my Apple Watch. The device includes a small sensor, placed just beneath the skin of my belly, and displays my blood glucose levels right on my Apple Watch…
October 17, 2016

How tech firm Dexcom is disrupting healthcare management

Digital healthcare has emerged as one of the central tenets of what’s been described by the World Economic Forum as the fourth industrial revolution. Technology has the ability to transform not only clinical diagnosis and treatments, but also empower individuals to take greater control over their…

Dexcom Company Life and Culture

You may also be interested in